This inventor holds 1 USPTO granted patent. Top assignee: The State University of New York. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Ken-Tye Yong: Innovator in Gene Expression Inhibition
Introduction
Ken-Tye Yong is a notable inventor based in Tonawanda, NY (US). He has made significant contributions to the field of gene expression inhibition through his innovative research and patents. His work focuses on utilizing advanced nanotechnology to develop methods for inhibiting target gene expression.
Latest Patents
Ken-Tye Yong holds a patent for a method of using gold nanorods-siRNA complexes. This patent provides methods and compositions for inhibiting the expression of one or more target genes. The compositions contain RNA polynucleotides that can inhibit expression via RNA interference (RNAi) when electrostatically complexed with surface functionalized gold nanorods (GNRs). Notably, the RNA polynucleotides are not covalently bound to the surface functionalized GNRs. The method involves administering an effective amount of a composition containing these GNRs complexed with RNA polynucleotides, such as siRNA, to inhibit the expression of the target gene.
Career Highlights
Ken-Tye Yong is affiliated with the State University of New York, where he continues to advance his research in the field of gene therapy and nanotechnology. His innovative approach has garnered attention in the scientific community, contributing to the understanding of gene regulation mechanisms.
Collaborations
Ken-Tye Yong has collaborated with esteemed colleagues, including Earl Jim Bergey and Adela Bonoiu. These collaborations have further enriched his research and expanded the impact of his work in the field.
Conclusion
Ken-Tye Yong's contributions to gene expression inhibition through his patented methods highlight the potential of nanotechnology in medical applications. His innovative research continues to pave the way for advancements in gene therapy and related fields.